TABLE 7.
Neonatal outcomes
| Parameter | EPA-rich fish oil (n = 40) | DHA-rich fish oil (n = 38) | Placebo (n = 40) | Significance |
|---|---|---|---|---|
| Birthweight (g), mean (SD) | 3402 (550) | 3774 (438) | 3309 (555) | < .001a–c |
| One minute Apgar, mean (SD) | 7.3 (2.2) | 7.9 (1.8) | 7.9 (1.9) | .19a |
| 5-minute Apgar, mean (SD) | 8.6 (0.8) | 9.1 (0.2) | 8.9 (0.5) | < .01a,d |
| Cord arterial pH, mean (SD) | 7.26 (0.09) (n = 34) | 7.27 (0.05) (n = 31) | 7.27 (0.06) (n = 31) | .54a |
| NICU admission, n (%) | 6 (15) | 2 (5) | 4 (10) | .39e |
ANOVA, analysis of variance; DHA, docosahexaenoic acid; EPA, eicosapentaenoic acid; NICU, neonatal intensive care unit; SD, standard deviation. Data are missing on 1 neonate who was not delivered at either study hospital.
a
One-way ANOVA, Kruskal-Wallis test for outliers;
b
Tukey’s multiple comparisons test;
c
The DHA group was greater than both the EPA and placebo groups;
d
Mann-Whitney (Wilcoxon) test;
e
Fisher exact test.